Faresay
Therapy, matched.

Risk Register

Confidential Faresay Ltd·25 June 2026

Working draft. Consistent with CONTEXT.md. Living document — review at least quarterly and on any material change. Scoring: Likelihood (L) and Impact (I) each 1–5; Rating = L×I (1–8 Low · 9–14 Medium · 15–25 High). Owners are roles, not named individuals yet. Last updated: [PLACEHOLDER: date]

How to use

Each risk has an ID, category, description, L, I, Rating, mitigation(s), and owner. Re-score after mitigations land (residual risk). ⚠️ flags cross-link to the policy/skill that addresses it.


ID Risk L I Rating Mitigation Owner
R-01 Fee-splitting / CPOM: the 15% is recharacterised as an unlawful split of clinical fees in some US states 4 5 20 High Frame 15% as technology/marketing platform fee; MSO/friendly-PC where required; per-state counsel sign-off (see legal skill) ⚠️ COUNSEL Founder/Legal
R-02 Operating without authority in a US state (entity not qualified / not registered) 3 5 15 High State-by-state qualification + registered agent before enabling bookings; state on/off switches gated by legal status Legal/Ops
R-03 Clinician licensure gap — client served by therapist not licensed in client's state 3 5 15 High Hard product rule: licensure-by-client-location; compact handling; ongoing licence monitoring Product/Clinical
R-04 Telehealth consent / modality non-compliance per state 3 4 12 Med Per-state informed consent capture; counsel review ⚠️ COUNSEL Legal/Product
R-05 Healthcare advertising rules breached (claims, testimonials) 2 3 6 Low Marketing/legal review of claims; review controls Marketing/Legal
R-06 Regulatory change (telehealth policy, state laws) outpaces compliance 3 3 9 Med Monitoring cadence; counsel relationship; agile state controls Legal
R-29 Corridor-choice / founder-convenience bias — first expat corridor steered by where the founder lives (Tokyo/Japan) rather than the legally cleanest market; Japan's posture is conservative/unsettled and the UAE is hostile (criminal exposure for unlicensed practice), risking a legal dead-end and wasted spend 4 4 16 High Choose the legally cleanest corridor first (e.g. Ireland / English-speaking EEA); gate corridor entry on a local legal memo ⚠️ COUNSEL (see cross-border-legal-gate.md) Founder/Legal

B. Clinical & safety

ID Risk L I Rating Mitigation Owner
R-07 Client harm / crisis (suicide, self-harm) where platform/therapist response is inadequate 2 5 15 High Crisis & Safeguarding Policy; screening/exclusion; persistent signposting (988/999); therapist training ⚠️ CLINICAL Clinical Lead
R-08 Unsuitable presentation taken on by cash-pay telehealth (high-acuity) 3 4 12 Med Defined exclusion criteria & triage at intake (clinical governance) ⚠️ CLINICAL Clinical Lead
R-09 Poor quality of care / practitioner competence issues 2 4 8 Low Credentialing, scope-of-practice limits, outcome monitoring, complaints route Clinical Lead
R-10 Duty-to-warn / mandatory reporting mishandled (state-variable) 2 5 10 Med Per-state matrix of triggers/recipients/timeframes; therapist training ⚠️ COUNSEL/CLINICAL Clinical/Legal
R-11 Safeguarding of minors/vulnerable adults fails 2 5 10 Med Safeguarding leads, reporting workflow, adults-only scope decision ⚠️ Clinical Lead

C. Data, privacy & security

ID Risk L I Rating Mitigation Owner
R-12 Data breach of special-category/PHI mental-health data 3 5 15 High Security & DP Policy; encryption, RBAC, MFA, logging; pen testing; incident response Security Lead/DPO
R-13 No BAA / sub-processor gap — PHI flows to a vendor without a BAA 3 4 12 Med BAA inventory; block PHI to non-BAA vendors ⚠️ COUNSEL/SECURITY Security/Legal
R-14 Unlawful international transfer (UK/EU → US) 3 3 9 Med SCCs/UK IDTA; transfer risk assessment; residency controls ⚠️ COUNSEL DPO/Legal
R-15 Trackers/analytics on a health site trigger HIPAA/MHMDA exposure 3 4 12 Med No health-data trackers; consent management; privacy review ⚠️ COUNSEL Product/DPO
R-16 Breach-notification timelines missed (ICO 72h / HIPAA / state AG) 2 4 8 Low Incident-response runbook with jurisdiction matrix Security Lead/DPO

D. Financial & commercial

ID Risk L I Rating Mitigation Owner
R-17 CAC exceeds LTV — cash-pay acquisition uneconomic 4 4 16 High Track CAC payback; lean spend; retention/sessions-per-client focus; organic channels (financial model) Founder/Growth
R-18 Take-rate pressure — 15% too low to cover costs, or undercut by rivals 3 3 9 Med Validate vs benchmarks; premium/B2B revenue options; cost discipline Founder
R-19 Compliance cost overrun (50-state legal/registration) as bootstrapped 4 3 12 Med Phase states; fixed-fee scoping; bundled registered-agent; approval gate on spend Founder/Legal
R-20 Payment failures / chargebacks / fraud 2 3 6 Low Reputable processor; fraud controls; clear refund/no-show terms Ops/Finance
R-21 Runway risk (bootstrapped) 3 4 12 Med Tight burn; contribution-margin-positive growth; milestone gating Founder

E. Market & operational

ID Risk L I Rating Mitigation Owner
R-22 Two-sided cold-start — can't balance supply & demand in a market 4 4 16 High Seed supply first per market; narrow launch geography; tight liquidity loops Founder/Growth
R-23 Incumbent competition (BetterHelp, Talkspace, Headway et al.) 4 3 12 Med Differentiation (fit, trust, therapist economics); niche/geographic focus Founder
R-24 Therapist churn / disintermediation (clients & therapists go off-platform) 3 3 9 Med Non-circumvention terms; ongoing platform value (payments, admin, leads) Product/Ops
R-25 Key-person / capacity risk (lean bootstrapped team) 3 3 9 Med Documentation; prioritisation; selective outsourcing Founder
R-26 Vendor dependency (video, payments, hosting outage) 2 3 6 Low Reputable vendors; monitoring; contingency options Engineering
R-30 GTM funnel volume shortfall — 100 paying clients implies ~16,700 targeted visitors (~90/day) from a brand-new domain in the planned window; SEO + anti-self-promo expat communities can't deliver that in 6 months, so Stage 0 likely misses on demand volume 4 4 16 High Re-sequenced GTM (therapist-led referral + paid validation); rebased timeline 9–12 months; funnel instrumented from day 1 Founder/Growth
R-31 Founder single-point-of-failure / bandwidth — solo bootstrapped founder must run supply + demand + product + per-corridor compliance + clinical simultaneously; predictable degradation of sales/retention work; key-person concentration (re-scores R-25 Higher) 4 4 16 High Ruthless 60-day focus on clients + founding-therapist retention; line up clinical lead / fractional compliance; concentrate not over-seed Founder

F. Reputational

ID Risk L I Rating Mitigation Owner
R-27 Safety incident or breach → trust collapse in a trust-dependent category 2 5 10 Med Strong safety/privacy posture; transparent comms; incident playbook Founder/Comms
R-28 Negative reviews / poor matches erode brand 3 3 9 Med Quality matching, feedback loops, responsive support Product/Support
R-32 Trust-at-zero (no reviews/brand at launch) — "trust is the product" but the first ~30 clients must convert with zero reviews, zero brand and no track record in a high-stakes mental-health purchase 3 4 12 Med Founder-as-guarantee; money-back first session; therapist credentials/testimonials front-loaded; verified badges + intro videos Founder/Growth

Top risks to watch (rating ≥ 15)